Our Approach
Health Disparities and Alzheimer’s Disease
In our social system, certain groups face significant barriers to access equitable health outcomes due to factors like income, housing, education, healthcare access, and discrimination—known as social determinants of health. These factors significantly influence susceptibility to Alzheimer's disease and its impact. For instance, underserved communities may have limited access to quality healthcare, leading to diagnostic delays.
Additionally, factors like poverty and lack of education can contribute to the development of unhealthy habits, leading to comorbidities that increase one's risk for Alzheimer's disease. Recognizing these dynamics acknowledges the fact that systemic barriers affect health outcomes. By integrating this understanding into our practices, we strive not only to deliver compassionate care but also to contribute to a larger collective journey towards health equity.
At Toronto Memory Program, clinical research represents a crucial opportunity to address present and future health disparities in Alzheimer's disease care, recognizing the barriers faced by marginalized communities. By offering quick and consistent access to specialized care, and advanced testing at no cost, clinical research aims to mitigate current disparities while simultaneously paving the way for future progress towards treatments that are effective for all.